What is known:
It has been shown earlier that decreasing the expression/activity of mTOR increases overall mammalian lifespan, suggesting that mTOR inhibitors may function as “longevity promoters.”
From research findings to therapeutic opportunity:
This study suggests that MiR-496, by suppressing the expression of mTOR, it may: (i) increase autophagic flux; (ii) decrease reactive oxygen species; and (iii) increase the lifespan of an individual.
Details of the research findings:
Idea Proposed/Formulated (with experimental evidence) by:
[easy_payment currency=”USD”]
Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Amount: $2#
For purchase and payment details, you may reach us at admin@genomediscovery.org
# Research cooperation
References:
Web: http://genomediscovery.org or http://newbioideas.com
Citation: Boominathan, L., MiRNA-based Life-span extension therapy: MiR-496 may increase lifespan by suppressing mTOR pathway, 20/March/2016, 5.35 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org